Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2018

June 2018 | 90 pages | ID: G50C7C15E01EN
QYResearch

Abstracts

This report studies the global Glucagon Like Peptide-1 (GLP-1) Agonists market status and forecast, categorizes the global Glucagon Like Peptide-1 (GLP-1) Agonists market size (value & volume) by key players, type, application, and region.
This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
United States is the largest consumer of Glucagon like peptide-1 (GLP-1) agonists with the production market share of 35% and the consumption market share of 44% in 2015.
The second place is Europe, following North America with the production market share of 63% and the consumption market share of 28% in 2015.
Market competition is intense. Novo Nordisk, AstraZeneca, Eli Lilly, GSK, Sanofi are the leader of the industry, and hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.

The global Glucagon Like Peptide-1 (GLP-1) Agonists market is valued at 5240 million US$ in 2017 and will reach 14200 million US$ by the end of 2025, growing at a CAGR of 13.3% during 2018-2025.

The major manufacturers covered in this report

• Novo Nordisk
• AstraZeneca
• Eli Lilly
• GSK
• Sanofi
• Bristol-Myers Squibb
• Amylin

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Exenatied
• Liraglutide
• Lixisenatide
• Albiglutide
• Dulaglutide

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Hospital
• Pharmacy
• Other

The study objectives of this report are:

• To analyze and study the global Glucagon Like Peptide-1 (GLP-1) Agonists sales, value, status (2013-2017) and forecast (2018-2025).
• Focuses on the key Glucagon Like Peptide-1 (GLP-1) Agonists manufacturers, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Glucagon Like Peptide-1 (GLP-1) Agonists are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturers
Glucagon Like Peptide-1 (GLP-1) Agonists Distributors/Traders/Wholesalers
Glucagon Like Peptide-1 (GLP-1) Agonists Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Glucagon Like Peptide-1 (GLP-1) Agonists market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2018

1 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET OVERVIEW

1.1 Product Overview and Scope of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Type (Product Category)
  1.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
  1.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share by Type (Product Category) in 2017
  1.2.3 Exenatied
  1.2.4 Liraglutide
  1.2.5 Lixisenatide
  1.2.6 Albiglutide
  1.2.7 Dulaglutide
1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Application
  1.3.1 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (Sales) Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Pharmacy
  1.3.4 Other
1.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Region (2013-2025)
  1.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
  1.4.2 North America Status and Prospect (2013-2025)
  1.4.3 Europe Status and Prospect (2013-2025)
  1.4.4 China Status and Prospect (2013-2025)
  1.4.5 Japan Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Status and Prospect (2013-2025)
  1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Glucagon Like Peptide-1 (GLP-1) Agonists (2013-2025)
  1.5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Status and Outlook (2013-2025)
  1.5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production Status and Outlook (2013-2025)

2 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production and Share by Manufacturers (2013-2018)
  2.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity and Share by Manufacturers (2013-2018)
  2.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production and Share by Manufacturers (2013-2018)
2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Share by Manufacturers (2013-2018)
2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution, Sales Area and Product Type
2.5 Glucagon Like Peptide-1 (GLP-1) Agonists Market Competitive Situation and Trends
  2.5.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration Rate
  2.5.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2013-2018)

3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity and Market Share by Region (2013-2018)
3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production and Market Share by Region (2013-2018)
3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2013-2018)

4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Region (2013-2018)
4.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export, Import (2013-2018)
4.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export, Import (2013-2018)
4.4 China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export, Import (2013-2018)
4.5 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export, Import (2013-2018)
4.7 India Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export, Import (2013-2018)

5 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production and Market Share by Type (2013-2018)
5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2013-2018)
5.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2013-2018)
5.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth by Type (2013-2018)

6 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET ANALYSIS BY APPLICATION

6.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Market Share by Application (2013-2018)
6.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MANUFACTURERS PROFILES/ANALYSIS

7.1 Novo Nordisk
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.1.4 Main Business/Business Overview
7.2 AstraZeneca
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Eli Lilly
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.3.4 Main Business/Business Overview
7.4 GSK
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Sanofi
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
  7.5.4 Main Business/Business Overview
7.6 Bristol-Myers Squibb
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Amylin
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.7.4 Main Business/Business Overview

8 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MANUFACTURING COST ANALYSIS

8.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2017
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET FORECAST (2018-2025)

12.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue Forecast (2018-2025)
  12.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production and Growth Rate Forecast (2018-2025)
  12.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate Forecast (2018-2025)
  12.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price and Trend Forecast (2018-2025)
12.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Import and Export Forecast by Region (2018-2025)
  12.2.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.4 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.5 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.6 India Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast by Application (2018-2025)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Exenatied
Table Major Manufacturers of Exenatied
Figure Product Picture of Liraglutide
Table Major Manufacturers of Liraglutide
Figure Product Picture of Lixisenatide
Table Major Manufacturers of Lixisenatide
Figure Product Picture of Albiglutide
Table Major Manufacturers of Albiglutide
Figure Product Picture of Dulaglutide
Table Major Manufacturers of Dulaglutide
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) by Applications (2013-2025)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Applications in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Players Product Capacity (K Units) (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity (K Units) of Key Manufacturers in 2017
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity (K Units) of Key Manufacturers in 2018
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Players Product Production (K Units) (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) of Key Manufacturers (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Manufacturers (2013-2018)
Figure 2017 Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Manufacturers
Figure 2017 Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Manufacturers
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Players Product Revenue (Million USD) (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers
Table 2018 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers
Table Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution and Sales Area
Table Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Category
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 3 Manufacturers
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 5 Manufacturers
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity (K Units) by Region (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity Market Share by Region (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity Market Share by Region (2013-2018)
Figure 2017 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity Market Share by Region
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production by Region (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) by Region (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share by Region (2013-2018)
Figure 2017 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share by Region
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) by Region (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2013-2018)
Table 2017 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) Market by Region (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Region (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Region (2013-2018)
Figure 2017 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) Market Share by Region
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) by Type (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Type (2013-2018)
Figure Production Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type (2013-2018)
Figure 2017 Production Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) by Type (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type (2013-2018)
Figure 2017 Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) by Type (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth by Type (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) by Application (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Applications (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application in 2017
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth Rate by Application (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth Rate by Application (2013-2018)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (Novo Nordisk) and Gross Margin (2013-2018)
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2013-2018)
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2013-2018)
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2013-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2013-2018)
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2013-2018)
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2013-2018)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2013-2018)
Figure Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2013-2018)
Figure Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2013-2018)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2013-2018)
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2013-2018)
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2013-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2013-2018)
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2013-2018)
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2013-2018)
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2013-2018)
Table Amylin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate (2013-2018)
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share (2013-2018)
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
Table Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2017
Table Major Buyers of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Distributors/Traders List
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (Million USD) and Trend Forecast (2018-2025)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) Forecast by Region (2018-2025)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share Forecast by Region (2018-2025)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share Forecast by Region (2018-2025)
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) and Growth Rate Forecast (2018-2025)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) Forecast by Type (2018-2025)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (K Units) Forecast by Type (2018-2025)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share Forecast by Type (2018-2025)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Type (2018-2025)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source